Invention Grant
- Patent Title: Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
-
Application No.: US16498690Application Date: 2018-03-27
-
Publication No.: US11920149B2Publication Date: 2024-03-05
- Inventor: Lay Khim Chuah , Thierry Vandendriessche , Warut Tulalamba
- Applicant: VRIJE UNIVERSITEIT BRUSSEL
- Applicant Address: BE Brussels
- Assignee: VRIJE UNIVERSITEIT BRUSSEL
- Current Assignee: VRIJE UNIVERSITEIT BRUSSEL
- Current Assignee Address: BE Brussels
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: EP 163080 2017.03.27
- International Application: PCT/EP2018/057753 2018.03.27
- International Announcement: WO2018/178067A 2018.10.04
- Date entered country: 2019-09-27
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K48/00 ; A61P21/00 ; C12N9/24 ; C12N9/26

Abstract:
The present invention relates to nucleic acid regulatory elements that are able to enhance diaphragm-specific expression of genes, in particular expression in diaphragm as such, or in combination with expression in cardiac muscle and/or skeletal muscle, methods employing these regulatory elements and uses of these elements. Expression cassettes and vectors containing these nucleic acid regulatory elements are also disclosed. The present invention is particularly useful for applications using gene therapy, more particularly diaphragm-directed gene therapy, and for vaccination purposes.
Information query
IPC分类: